Our results show that the reduction in frequency and number of eosinophils and CD11c+CD11b+ cells were accompanied by a reduction in IL-22 concentrations, confirming that IL-22 acts as a pro-inflammatory mediator in the airway allergy inflammation. Here, ITGAX is linked to allergic disease.